```

[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Pages 94748-94749]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28075]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Meetings of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that an in-person meeting is scheduled to be held for the Presidential 
Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); 
the main focus of the meeting is to solicit feedback from invited 
presenters and members of the public on the 2025-2020 National Action 
Plan on Combating Antibiotic Resistant Bacteria. The meeting will be 
open to the public as well as streamed live on hhs.gov/live. A pre-
registered public comment and innovation spotlight session will be held 
during the meeting. Pre-registration is required for members of the 
public who wish to present their comments or innovations live during 
the meeting.

DATES: The meeting is scheduled to be held on January 28-29, 2025, from 
9 a.m. to 5 p.m. ET (times are tentative and subject to change). The 
confirmed times and agenda items for the meeting will be posted on the 
website for the PACCARB at https://www.hhs.gov/paccarb when this 
information becomes available. Pre-registration for attending the 
meeting is strongly suggested and should be completed no later than 
January 24, 2025.

ADDRESSES: The meeting will be held in-person at The Ritz-Carlton, 
Pentagon City, 1250 S. Hayes St., Arlington, VA 22202. The meeting will 
also be live streamed and can be accessed through a live webcast on the 
day of the meeting. Additional instructions regarding attending this 
meeting virtually will be posted at least one week prior to the meeting 
at: https://www.hhs.gov/paccarb.
    Individuals who wish to send in their written public comment should 
submit it via email to [email protected]. Registration information is 
available on the website https://www.hhs.gov/paccarb and must be 
completed by January 24, 2025, to attend the January 28-29, 2025, 
public meeting or by January 21, 2025, to provide public comment or 
innovation spotlight at the meeting. Additional information about 
registering for the meeting and providing public comment can be 
obtained at https://www.hhs.gov/paccarb on the Upcoming Meetings page.

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, 1101 Wootton Parkway, 
Rockville, MD 20852. Phone: 202-746-1512; Email: [email protected].

SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria (PACCARB), established by 
Executive Order 13676, is continued by section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation 
Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are 
governed by the provisions of the Federal Advisory Committee Act 
(FACA), Public Law 92-463, as amended (5 U.S.C. app.), which sets forth 
standards for the formation and use of Federal advisory committees.
    The PACCARB shall advise and provide information and 
recommendations to the Secretary of Health and Human Services 
(Secretary) regarding programs and policies intended to reduce or 
combat antibiotic-resistant bacteria that may present a public health 
threat and improve capabilities to prevent, diagnose, mitigate, or 
treat such resistance. The PACCARB shall function solely for advisory 
purposes.
    Such advice, information, and recommendations may be related to 
improving: the effectiveness of antibiotics; research and advanced 
research on, and the development of, improved and innovative methods 
for combating or reducing antibiotic resistance, including new 
treatments, rapid point-of-care diagnostics, alternatives to 
antibiotics, including alternatives to animal antibiotics, and 
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health 
care providers and the public with respect to up-to-date information on 
antibiotic resistance and ways to reduce or combat such resistance to 
antibiotics related to humans and animals; methods to prevent or reduce

[[Page 94749]]

the transmission of antibiotic-resistant bacterial infections; 
including stewardship programs; and coordination with respect to 
international efforts in order to inform and advance the United States 
capabilities to combat antibiotic resistance.
    The focus of the January 28-29, 2025, meeting is to provide input 
and information to the Combating Antibiotic-Resistant Bacteria (CARB) 
Federal Task Force as they develop the next five-year iteration of the 
CARB National Action Plan 2025-2030. The meeting will focus on 
innovative and emerging topics in antimicrobial resistance (AMR), as 
well as insights from international CARB counterparts. The topics 
presented at the public meeting include: an overview of other partner 
country CARB National Action Plans; methods to measure global awareness 
of AMR; the impact of AMR and food security; AMR as a national security 
threat; a reflection on the United Nations General Assembly Political 
Declaration by Federal agencies; the economics of AMR; innovations to 
combat AMR; among other topics.
    Members of the public are invited to provide comment, especially on 
the 2025-2030 CARB National Action Plan, during an extended public 
comment session, in-person during the meeting by pre-registering online 
at https://www.hhs.gov/paccarb; pre-registration is required for 
participation in this session. Additionally, companies or organizations 
working to combat antimicrobial resistance my share their innovation 
during the January meeting by pre-registering to speak during the 
meeting's Innovation Spotlight. Pre-registration online at https://www.hhs.gov/paccarb is required for participation in this session, and 
limited spots are available. The meeting agenda will be posted on the 
PACCARB website at https://www.hhs.gov/paccarb when it has been 
finalized. All agenda items are tentative and subject to change. 
Instructions regarding attending the meeting virtually will be posted 
at least one week prior to the meeting at: https://www.hhs.gov/paccarb. 
For those unable to attend in person, but who wish to provide input 
into the next iteration of the CARB National Action Plan 2025-2030, may 
provide written public comments that can be emailed to [email protected] by 
midnight January 21, 2025. All public comments received via email prior 
to January 21, 2025, will be provided to the PACCARB and Interagency 
CARB Task Force members.

    Dated: November 18, 2024.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for 
Health.
[FR Doc. 2024-28075 Filed 11-27-24; 8:45 am]
BILLING CODE 4150-44-P
```